ADVANCED SOLID TUMOR CANCER
Clinical trials for ADVANCED SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing an experimental drug called Trastuzumab Rezetecan for people with advanced HER2-positive cancers that have stopped responding to standard treatments. The trial will enroll 90 participants with specific rare or hard-to-treat tumors to see if the drug can shri…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug combo enters human testing for Tough-to-Treat lung cancers
Disease control Recruiting nowThis is an early-stage trial testing a new drug called HC010 when given alongside standard chemotherapy to people with advanced lung cancer. The main goals are to find a safe and tolerable dose and to get a first look at whether the combination might help control the cancer. The …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo trial offers hope for Tough-to-Treat advanced cancers
Disease control Recruiting nowThis study is testing whether a new drug called LM-24C5, when combined with other cancer treatments, is safe and effective for people with advanced solid tumors that have a specific marker called CEACAM5. It will enroll about 130 adults whose cancer has returned or hasn't respond…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Early test of new cancer drug combo launches
Disease control Recruiting nowThis is an early-stage study to find a safe and effective dose of a new drug called ABBV-CLS-484. It will be tested alone and in combination with other cancer therapies in about 248 adults with advanced solid tumors that have not responded to standard treatments. The main goals a…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug combo enters human testing
Disease control Recruiting nowThis early-stage study aims to find a safe and tolerable dose of an investigational drug called HC010 when given alongside standard chemotherapy to people with advanced solid tumors, particularly gastrointestinal cancers. Researchers will closely monitor side effects and how the …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New Light-Activated cancer injection enters human testing
Disease control Recruiting nowThis is an early-stage safety study testing a new treatment called X-PACT for people with advanced solid tumors that have spread or returned. The treatment involves injecting a drug and a special material directly into a tumor, then applying X-ray energy to activate it. The main …
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC